![]() |
|
|
Vol. 63, Issue 1, 89-95, January 2003
-Opioid Receptors with µ Receptors in
GH3 Cells Changes the Functional Response to µ Agonists
from Inhibitory to Excitatory
Departments of Neurology (A.C., N.M., K.A.) and Psychiatry (C.E.),
UCLA School of Medicine, Los Angeles, California; and Department of
Pharmacology, the George Washington University, Washington, DC (M.L.D.,
T.G.H.)
GH3 cells show spontaneous activity characterized by bursts
of action potentials and oscillations in
[Ca2+]i. This activity is modulated by the
activation of exogenously expressed opioid receptors. In
GH3 cells expressing only µ receptors (GH3MOR
cells), the µ receptor-specific ligand
[D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin
(DAMGO) inhibited spontaneous Ca2+ signaling by the
inhibition of voltage-gated Ca2+ channels, activation of
inward-rectifying K+ channels, and inhibition of adenylyl
cyclase. In contrast, in cells expressing both µ and
receptors
(GH3MORDOR cells), DAMGO had an excitatory effect on
Ca2+ signaling that was mediated by phospholipase C and
release of Ca2+ from intracellular stores. The excitatory
effect of DAMGO was also inhibited by pretreatment with pertussis
toxin. Despite the excitatory effect on Ca2+ signaling,
DAMGO inhibited Ca2+ channels and activated
inward-rectifying K+ channels in GH3MORDOR
cells, although to a lesser extent than in GH3MOR cells.
Long-term treatment with the
receptor-specific ligand
[D-Pen2,D-Pen5]-enkephalin
reduced the excitatory effect of DAMGO in the majority of
GH3MORDOR cells and restored the inhibitory response to
DAMGO in some cells. The inhibitory effect of somatostatin on
Ca2+ signaling was not different in GH3MORDOR
versus GH3MOR cells. These results indicate that
interaction between µ- and
-opioid receptors causes a change in
the functional response to µ ligands, possibly by the formation of a
µ/
heterodimer with distinct functional properties.
This article has been cited by other articles:
![]() |
R. Rozenfeld and L. A. Devi Receptor heterodimerization leads to a switch in signaling: {beta}-arrestin2-mediated ERK activation by {micro}-{delta} opioid receptor heterodimers FASEB J, August 1, 2007; 21(10): 2455 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Lee, C. H. So, A. J. Rashid, G. Varghese, R. Cheng, A. J. Lanca, B. F. O'Dowd, and S. R. George Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal J. Biol. Chem., August 20, 2004; 279(34): 35671 - 35678. [Abstract] [Full Text] [PDF] |
||||